Extent of investigation and management of cases of 'unexplained' mismatch repair deficiency (u-dMMR): a UK Cancer Genetics Group consensus.

Terri Patricia McVeighKevin J MonahanJoseph ChristopherNick WestMalcolm ScottJennie MurrayHelen Hansonnull null

Published in: Journal of medical genetics (2024)

Decisions regarding investigations and future cancer risk management in patients and relatives should be nuanced, considering factors like clinical suspicion of hereditary predisposition to allocate limited resources efficiently and avoid unnecessary investigations in low-suspicion families.

Keyphrases

end stage renal disease
newly diagnosed
prognostic factors
papillary thyroid
squamous cell
replacement therapy
young adults
clinical practice
patient reported
smoking cessation